Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol versus dexmedetomidine for controlled hypotension during rhinoplasty
IRCT20141209020258N171Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rhinoplasty comparing Labetalol infusion with Dexmedetomidine infusion (2 arms). Primary endpoints: Sedation and Bleeding. Started Jan 2022; status: completed.
02
Drugs
labetaloldexmedetomidine
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20141209020258N171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N171.